Treating Hematologic Malignancies and Advancing Equitable Care

ECHO series for hematology/oncology professionals

Join the American Cancer Society, Blood Cancer United and NMDPSM for the Treating Hematologic Malignancies in the Community and Advancing Equitable Care ECHO. Through case-based learning and expert-led discussion, participants will enhance clinical decision-making, explore evidence-based approaches to hematologic malignancies and advance equitable, high-quality care in community settings.

Participation is free and open to all. Join any of the six sessions live and access recordings throughout the series.

Register for the series (Opens in a new tab)
Download a flier for your team (Opens in a new tab)

Upcoming live ECHO sessions

  • The words Multiple Myeloma in white on a blue textured background.

    Session 1

    Multiple Myeloma
    Wednesday, Aug. 19 | 4–5 p.m. ET

    Session focus:

    • Multiple myeloma diagnosis, treatment planning and barriers to care
    Watch now (Opens in a new tab)
  • The words CLL in white on a blue textured background.

    Session 2

    Chronic Lymphocytic Leukemia
    Wednesday, Sept. 23 | 1–2 p.m. ET

    Session focus:

    • Long-term adherence, financial toxicity and supportive care
    Register (Opens in a new tab)
  • The words MDS and AML in white on a blue textured background.

    Session 3

    MDS and AML
    Wednesday, Oct. 21 | 4–5 p.m. ET

    Session focus:

    • Transplant referral barriers and care coordination
    Register (Opens in a new tab)
  • The words Non-Hodgkin Lymphoma in white on a blue textured background.

    Session 4

    Non-Hodgkin Lymphoma
    Monday, Nov. 16 | 1–2 p.m. ET

    Session focus:

    • CAR-T referral barriers, health literacy and patient engagement
    Register (Opens in a new tab)
  • The word ALL in white on a blue textured background.

    Session 5

    Acute Lymphoblastic Leukemia
    Wednesday, Dec. 2 | 4–5 p.m. ET

    Session focus:

    • Culturally responsive care and language access
    Register (Opens in a new tab)
  • The words Post-HCT and CAR-T Care in white on a blue textured background.

    Session 6

    Post-Transplant and CAR-T Care
    Monday, Jan. 25 | 1–2 p.m. ET

    Session focus:

    • Survivorship, long-term support and recovery after transplant or CAR-T therapy
    Register (Opens in a new tab)

Who should participate

The series is designed for community cancer clinicians and multidisciplinary oncology care teams—including physicians, advanced practice providers, nurses, navigators and psychosocial professionals—seeking to strengthen the diagnosis, treatment and supportive care of patients with blood cancers.

Faculty

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO
Associate Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Duke University School of Medicine
Founding Director
Cancer Patient Experience Research Program (CPEP)
Duke Cancer Institute

Jonathan Moreira, MD
Associate Professor of Medicine
Department of Medicine
Division of Hematology/Oncology
Northwestern University's Feinberg School of Medicine

Joanne E. Filicko-O'Hara, MD
Associate Program Director, Combined Fellowship
Hematology/Medical Oncology Professor
Thomas Jefferson University
Jane Dabney, LISW-S, OSW-C
Social Worker
Blood & Marrow Transplant Program
The Cleveland Clinic Foundation

Harold Dean, LCSW, OSW-C, FAOSW 
Clinical Social Work Program Manager
University of Arkansas for Medical Sciences Myeloma Center

ECHO activity providers

This ECHO activity is provided by the American Cancer Society, Blood Cancer United and NMDP.

American Cancer Society logo
Blood Cancer United logo
NMDP logo
Project ECHO logo